GMG

Clinical trials for GMG explained in plain language.

Never miss a new study

Get alerted when new GMG trials appear

Sign up with your email to follow new studies for GMG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 5 Not yet recruiting 2 Not yet finished but already full! 3 Completed 1

New dosing strategy for myasthenia gravis drug shows promise

Disease control Completed

This study tested two different ways of giving the drug efgartigimod to people with generalized myasthenia gravis, a condition that causes muscle weakness. One group received the drug continuously, while the other got it in cycles. The goal was to see which schedule works better …

Matched conditions: GMG

Phase: PHASE3 • Sponsor: argenx • Aim: Disease control

Last updated Jun 27, 2026 12:37 UTC

GMG

Get alerted when new GMG trials appear

New dosing strategy for myasthenia gravis drug shows promise